Glenmede Trust’s Danimer Scientific, Inc. DNMR Stock Holding History

Glenmede Trust’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-277	Closed	-$418K	–	1323
2021 Q1	$418K	Buy	+277	New	+$450K	﹤0.01%	896

Other funds holding DNMR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

HCM

Heathbridge Capital Management Toronto, Ontario, Canada $275M AUM 28.95% 1-Year Est. Return

Glenmede Trust's DNMR Position: Q2 2021 in Review

Glenmede Trust sold out of Danimer Scientific, Inc. (DNMR) in Q2 2021, closing a stake of 277 shares — an estimated $418K sold.

Glenmede Trust first reported a position in DNMR in Q1 2021 and held it in 1 quarter. The position peaked at $418K in Q1 2021. 217 funds tracked by Wall St. Rank hold DNMR as of Q2 2021.

Glenmede Trust reported no remaining Danimer Scientific, Inc. position as of Q2 2021 after selling out during the quarter.
Glenmede Trust sold 277 Danimer Scientific, Inc. shares in Q2 2021, an estimated $418K.
Glenmede Trust first reported a position in Danimer Scientific, Inc. in Q1 2021 and held it in 1 quarter.
Glenmede Trust's Danimer Scientific, Inc. position peaked at $418K in Q1 2021.
217 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q2 2021.

Based on Glenmede Trust's 13F filing for Q2 2021, filed 16 Aug 2021.